Spotlight on Rubitection: Advancing Early Bedsore Detection
Treating a single bedsore can cost up to $45,000, and some patients pay with their lives. Rubitection, a Luminate cohort 3 startup, is working to change the outcomes. Dr. Sanna Gaspard, Rubitection CEO, shares how her company’s skin health monitoring platform, the Rubitect Assessment System (RAS), offers a much needed and vastly superior alternative to the manual blanch test for bedsore detection. Hear about Dr. Gaspard’s experience in the Luminate accelerator, why she founded her startup, and her hopes for the future of Rubitection in the broader skin care market.
Subscribe to Forward Faster
